Augmentation of Ischemia/Reperfusion Injury to Endothelial Cells by Cyclosporin A

Azizian, Maria; Ramenaden, E. Radhika; Shah, Gaurang; Wilasrusmee, Chumpon; Bruch, David; Kittur, Dilip S.
May 2004
American Surgeon;May2004, Vol. 70 Issue 5, p438
Academic Journal
Ischemia/reperfusion (I/R) carries significant injury to endothelial cells in transplanted organs and is an important factor in chronic rejection. Immunosuppressive drugs, notably cyclosporin A (CyA) and FK506, can potentially augment this injury. Here, our goal was to determine the combined effects of I/R and CyA or FK506 on endothelial cells. Transformed mouse endothelial cells (SVEC 4-10) were subjected to ischemia or I/R for 2-24 hours by incubating cells in 100 per cent N2 (ischemia) followed by 5 per cent CO2 and 95 per cent O2 (reperfusion) for 24 hours. In separate experiments, CyA or FK506 was added to cells subjected to ischemia or I/R. Nonviable cells were determined by Trypan blue exclusion assay. All experiments (done in triplicate) were analyzed by Student's t test. Increasing ischemia times resulted in a greater number of nonviable cells (2% nonviable cells at 0 hours and 57% at 24 hours of I/R). Addition of CyA significantly increased the number of nonviable cells when compared with the control (I/R only) group (P = 0.014). Interestingly, FK506 did not increase the percentage of nonviable cells compared with the control group (P = 0.2). Unlike FK506, CyA augments I/R injury to endothelial cells in vitro. These findings could be relevant in chronic rejection and transplantation.


Related Articles

  • Lower Extremity and Renal Ischemia Following Renal Transplantation -- A Case Report. Fanning, William J.; Henry, Mitchell L.; Sommer, Bruce G.; Ferguson, Ronald M. // Vascular Surgery;May/Jun1989, Vol. 23 Issue 3, p231 

    Renal transplantation in the older recipient has become commonplace. As the age range continues to widen, it is inevitable that one encounters age-related complications in this group, particularly that of advanced atherosclerosis. Literature regarding the management of patients with a previously...

  • Rifampicin interaction.  // Reactions Weekly;10/22/2005, Issue 1074, p10 

    Highlights a case report about a man receiving mycophenolate mofetil and tacrolimus immunosuppressive therapy following a heart double-lung transplant who developed decreased serum concentrations of the drugs during concomitant treatment with rifampicin. Discovery of a Ziehl-stain positive...

  • Steroid elimination is coming of age. Sarwal, Minnie // Pediatric Nephrology;Jan2006, Vol. 21 Issue 1, p2 

    Steroid elimination is being achieved in organ transplantation. The newer generation of more powerful induction and maintenance immunosuppressants offer a new era of safe and effective steroid avoidance. The advantages of achieving independence from steroids definitely extend to the patient....

  • mycophenolate mofetil. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p526 

    A definition of the term "mycophenolate mofetil," which refers to an immunosuppresant drug used following organ transplanted to reduce the risk of the body rejecting the organ, is presented.

  • Ischemia–reperfusion treatment: opportunities point to modulation of the inflammatory response. Rouschop, K. M. A.; Leemans, J. C. // Kidney International;Jun2008, Vol. 73 Issue 12, p1333 

    Ischemia–reperfusion injury is the leading cause of acute renal failure and determinant of renal-transplant outcome. Although many experimental studies show decreased injury and preserved renal function after dampening of the inflammatory response, surprisingly little progress has been...

  • Nationwide organ sharing using HLA typing. Terasaki, Paul I. // Kidney International;Mar1991, Vol. 39 Issue 3, p557 

    This article presents information on a case study related to the human leukocyte antigen typing (HLA). The patient is an obese, 100 kg female who has been awaiting renal transplantation for 3 years. She is highly sensitized because of prior pregnancies, and her panel of reactive antibodies has...

  • Kidney graft survival in Italy and factors influencing it. Pugliese, Orsola; Quintieri, Francesca; Mattucci, Dino Alberto; Venettoni, Sante; Taioli, Emanuela; Costa, Alessandro Nanni // Progress in Transplantation;Dec2005, Vol. 15 Issue 4, p385 

    Purpose--National registry data are often a suitable basis for examination of transplant outcomes. Using data supplied by the Italian National Transplant Registry, established in 1995, we performed the first nationwide analysis of this kind. Methods--A retrospective analysis of 4893 recipients...

  • Ischemia-Reperfusion Injury. Dorweiler, Bernhard; Pruefer, Diethard; Andrasi, Terezia; Maksan, Sasa; Schmiedt, Walther; Neufang, Achim; Vahl, Christian // European Journal of Trauma & Emergency Surgery;Dec2007, Vol. 33 Issue 6, p600 

    The term ischemia-reperfusion injury describes the experimentally and clinically prevalent finding that tissue ischemia with inadequate oxygen supply followed by successful reperfusion initiates a wide and complex array of inflammatory responses that may both aggravate local injury as well as...

  • Protection by LPS-Conditioning of Rat Livers against Cold Preservation-Reperfusion Injury; Differences in Male Versus Female Donor Organs. El-Gibaly, A. M.; Vollmai, B.; Menger, M. D. // European Surgical Research;May/Jun2004 Supplement 1, Vol. 36, p29 

    Despite recent advances in the field of transplantation, primary graft dysfunction or non-function still constitutes a major problem in liver transplantation. Current principles of organ preservation strive chiefly for conferring optimal primary organ function. Endotoxin pretreatment was...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics